Monday, May 2, 2022

< + > Asthma Medication Points The Way To Drugs To Prevent And Treat Covid-19: Nsp1, A Novel Target

Montelukast, an asthma drug, can bind to and block a crucial SARS-CoV-2 protein. This discovery sets the stage for a new class of antiviral drugs, designed to target and interfere with the virus' immunosuppressive tactics.

No comments:

Post a Comment

< + > Health Recovery Solutions Acquires Rimidi | Messagepoint Acquires Sefas

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare ...